TY - JOUR
T1 - Liposomes as vehicles for water insoluble platinum-based potential drug
T2 - 2-(4-(tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II)
AU - Kaluđerović, Goran N
AU - Dietrich, Andrea
AU - Kommera, Harish
AU - Kuntsche, Judith
AU - Mäder, Karsten
AU - Mueller, Thomas
AU - Paschke, Reinhard
N1 - Copyright © 2012 Elsevier Masson SAS. All rights reserved.
PY - 2012
Y1 - 2012
N2 - Formulation of liposome delivery system loaded with water insoluble 2-(4-(tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II), LipoTHP-C11 was carried out. The particle size distributions were determined by dynamic light scattering and asymmetrical flow field-flow fractionation indicating size of around 120 nm. Stability study showed that LipoTHP-C11 was stable at 4 °C for more than two months. To test suitability of chosen formulation, LipoTHP-C11 was investigated against several tumor cell lines: H12.1, 1411HP, 518A2, A549, HT-29, MCF-7 and SW1736. Furthermore, toxicity against normal fibroblasts was examined. LipoTHP-C11 may be used as an attractive candidate for further assessment in vivo as antitumor agent.
AB - Formulation of liposome delivery system loaded with water insoluble 2-(4-(tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II), LipoTHP-C11 was carried out. The particle size distributions were determined by dynamic light scattering and asymmetrical flow field-flow fractionation indicating size of around 120 nm. Stability study showed that LipoTHP-C11 was stable at 4 °C for more than two months. To test suitability of chosen formulation, LipoTHP-C11 was investigated against several tumor cell lines: H12.1, 1411HP, 518A2, A549, HT-29, MCF-7 and SW1736. Furthermore, toxicity against normal fibroblasts was examined. LipoTHP-C11 may be used as an attractive candidate for further assessment in vivo as antitumor agent.
KW - Antineoplastic Agents
KW - Cell Line, Tumor
KW - Humans
KW - Inhibitory Concentration 50
KW - Liposomes
KW - Organoplatinum Compounds
KW - Solubility
KW - Water
U2 - 10.1016/j.ejmech.2012.06.004
DO - 10.1016/j.ejmech.2012.06.004
M3 - Journal article
C2 - 22749394
SN - 0223-5234
VL - 54
SP - 567
EP - 572
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
ER -